Gertrud Wiedemann

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Quantifying endothelial damage by digital droplet polymerase chain reaction (PCR) of endothelial cell-free DNA in COVID-19 patients.

Quantifying endothelial damage by digital droplet polymerase chain reaction (PCR) of endothelial cell-free DNA in COVID-19 patients.

Journal: Research and practice in thrombosis and haemostasis

Published: August 28, 2025

Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma.

Clonal Hematopoiesis and Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with AML, Myeloma, and Lymphoma.

Journal: International journal of molecular sciences

Published: July 01, 2025

Artificial Intelligence in Haematologic Diagnostics: Current Applications and Future Perspectives.

Artificial Intelligence in Haematologic Diagnostics: Current Applications and Future Perspectives.

Journal: Acta haematologica

Published: April 25, 2025

A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications.

A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications.

Journal: International journal of molecular sciences

Published: June 26, 2024

An ancient role for CYP73 monooxygenases in phenylpropanoid biosynthesis and embryophyte development.

An ancient role for CYP73 monooxygenases in phenylpropanoid biosynthesis and embryophyte development.

Journal: The EMBO journal

Published: October 29, 2023

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: July 31, 2023

Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma.

Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma.

Journal: Hematological oncology

Published: March 19, 2023

CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma.

CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma.

Journal: International journal of molecular sciences

Published: February 12, 2023

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients.

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients.

Journal: BMC cancer

Published: January 19, 2023

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.

Journal: Cells

Published: July 13, 2022

Adaptive evolution of the enigmatic Takakia now facing climate change in Tibet.

Adaptive evolution of the enigmatic Takakia now facing climate change in Tibet.

Journal: Cell

Published: June 30, 2022

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy.

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy.

Journal: Cancers

Published: April 26, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026